文献速递流行病学与生物统计临床试验与 GCP

白蛋白尿作为肾衰竭替代终点的荟萃分析

A meta-analysis of albuminuria as a surrogate endpoint for kidney failure.
PubMed 文献 · Nat Med · 2025-11-06

该研究对48项随机对照试验、85,681例参与者的个体数据进行荟萃分析,评估治疗6个月时尿白蛋白肌酐比(UACR)变化与肾衰竭或血清肌酐加倍这一临床终点的关联。结果显示,治疗组相对对照组UACR几何均值每降低30%,临床终点风险平均降低19%(95% BCI:5-30%),中位决定系数R²=0.66(95% BCI:0.06-0.98),未见该关联随CKD病因变异的明确证据。

要点

  • 治疗组相对对照组UACR几何均值每降低30%,临床终点风险平均降低19%(95% BCI:5-30%)。
  • 中位决定系数R²=0.66(95% BCI:0.06-0.98)。
  • 未见该关联随CKD病因变异的明确证据。

核心结论

  • 这些结果进一步支持将白蛋白尿变化作为CKD临床试验的替代终点。

研究设计与样本

  • 个体参与者数据分析,纳入48项随机对照试验,共85,681例参与者。

主要发现

  • 在所有试验中,治疗组相对对照组UACR几何均值每降低30%,临床终点风险平均降低19%(95% BCI:5-30%)。
  • 中位决定系数R²=0.66(95% BCI:0.06-0.98)。
  • 未见该关联随CKD病因变异的明确证据。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Albuminuria is a central biomarker in chronic kidney disease (CKD), used for the detection and prognosis of the disease. In clinical trials assessing CKD progression, change in the level of albuminuria is a candidate surrogate endpoint for kidney failure. Evaluation of the validity of this surrogate endpoint across a diverse range of interventions and populations is required to support its further acceptance. Here, in an individual participant data analysis of 48 randomized controlled trials (studies) involving 85,681 participants, we assessed the association between treatment effects on 6-month urinary albumin:creatinine ratio (UACR) change and the established clinical endpoint of kidney failure or doubling of serum creatinine concentrations. Across all trials, each 30% reduction in the geometric mean of the UACR in the treatment group relative to the control group was associated with an average of 19% lower hazard for the clinical endpoint (95% Bayesian credible interval (BCI): 5-30%); median coefficient of determination (R2) = 0.66 (95% BCI: 0.06-0.98). There was no clear evidence that this association varied by CKD etiology. These results provide further support for use of albuminuria change as a surrogate endpoint in CKD clinical trials.

来源:Nat Med,查看原文。版权归原作者所有。

引用

  1. Heerspink HJL, Collier WH, Chaudhari J, et al. A meta-analysis of albuminuria as a surrogate endpoint for kidney failure. Nat Med. 2025. PMID: 41198855. doi:10.1038/s41591-025-04057-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。